Fougera Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Fougera Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					           Fougera Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and
                                     Alliances Profile
       Reference Code: GDPH84325D                                                                                                            Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Fougera Pharmaceuticals Inc. (Fougera Pharmaceuticals) is a dermatology-focused
                                                                                                              Fougera Pharmaceuticals Inc., Pharmaceuticals &
      pharmaceutical company, based in the US. The company manufactures topical
                                                                                                              Healthcare, Key Facts
      pharmaceuticals products for dermatology market in the US. Its core divisions
      include PharmaDerm and Fougera - E. Fougera & Company. PharmaDerm is a fully                             Web Address                      www.fougerapharmaceu
      vertically integrated pharmaceutical company dedicated to skin disease with in-                                                           ticals.com
      house expertise and facilities for formulation development, clinical development,
                                                                                                               Revenue (US$ million)                           NA
      manufacturing, distribution, and sales and marketing. Fougera - E. Fougera &
      Company is Fougera Pharmaceuticals’ generic drug division, which primarily                               Number of Employees                             NA
      produces multi-source prescription and OTC dermatologic preparations.                                    GlobalData

      Financial Deals Landscape
        Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare,                       Fougera Pharmaceuticals Inc., Pharmaceuticals &
        Deals by Type, 2007 to YTD 2013                                                   Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                                    1    1               1
                                                                                                          1

                                                                                           No. of Deals



                                                                                                                 0        0                     0                  0
                                                                                                          0
                                                                                                               2007      2008   2009    2010   2011     2012    YTD
                                                                                                                                                                2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Fougera Pharmaceuticals Inc., Pharmaceuticals &                                  Fougera Pharmaceuticals Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013


                         3                                                                                           2
          No. of Deals




                                                                                           No. of Deals




                               3                                                                          2
                         2
                                        1                                                                                       1        1          1          1
                         1                                                                                1
                                                 0         0         0
                         0
                             North    Europe    Asia-    Middle   South                                   0
                             Americ            Pacific    East     and                                          Ophthal Cardiov Central Dermat               Immun
                               a                          and     Central                                       mology ascular Nervou ology                   ology
                                                         Africa   Americ                                                           s
                                                                    a                                                           System



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Fougera Pharmaceuticals Inc. - Pharmaceuticals & Healthcare -                                                                                  Reference Code: GDPH84325D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................................. 3
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013................................................... 5
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .............................................. 6
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .................................... 7
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................... 8
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deal Details..................................................................................... 9
          Partnerships.................................................................................................................................................................................... 9
             BTG Enters Into Co-Marketing Agreement With Nycomed ......................................................................................................... 9
          Asset Transactions ....................................................................................................................................................................... 10
             Fera Pharma Acquires Portfolio Of Ophthalmic Ointments ....................................................................................................... 10
          Acquisition .................................................................................................................................................................................... 11
             Novartis Completes Acquisition Of Fougera Pharma, Dermatology Company, For $1.5 Billion ................................................ 11
       Fougera Pharmaceuticals Inc. - Key Competitors ............................................................................................................................ 14
       Key Employees ................................................................................................................................................................................ 15
       Locations And Subsidiaries .............................................................................................................................................................. 16
          Head Office ................................................................................................................................................................................... 16
          Other Locations & Subsidiaries ..................................................................................................................................................... 16
       Appendix .......................................................................................................................................................................................... 17
          Methodology ................................................................................................................................................................................. 17
          About GlobalData ......................................................................................................................................................................... 17
          Contact Us .................................................................................................................................................................................... 17
          Disclaimer ..................................................................................................................................................................................... 17




Fougera Pharmaceuticals Inc. - Pharmaceuticals & Healthcare -                                                                                                      Reference Code: GDPH84325D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Key Facts ........................................................................................ 1
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................................. 1
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .............................................. 1
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .................................... 1
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................................. 4
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013................................................... 5
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .............................................. 6
       Fougera Pharmaceuticals Inc., Deals By Therapy Area, 2007 to YTD 2013 ...................................................................................... 7
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................... 8
       BTG Enters Into Co-Marketing Agreement With Nycomed................................................................................................................. 9
       Fera Pharma Acquires Portfolio Of Ophthalmic Ointments .............................................................................................................. 10
       Novartis Completes Acquisition Of Fougera Pharma, Dermatology Company, For $1.5 Billion ....................................................... 11
       Fougera Pharmaceuticals Inc., Key Competitors ............................................................................................................................. 14
       Fougera Pharmaceuticals Inc., Key Employees ............................................................................................................................... 15
       Fougera Pharmaceuticals Inc., Other Locations............................................................................................................................... 16


       List of Figures
       Fougera Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 .................................................. 1
       Fougera Pharmace
				
DOCUMENT INFO
Description: Fougera Pharmaceuticals Inc. (Fougera Pharmaceuticals) is a dermatology-focused pharmaceutical company, based in the US. The company manufactures topical pharmaceuticals products for dermatology market in the US. Its core divisions include PharmaDerm and Fougera - E. Fougera & Company. PharmaDerm is a fully vertically integrated pharmaceutical company dedicated to skin disease with in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. Fougera - E. Fougera & Company is Fougera Pharmaceuticals’ generic drug division, which primarily produces multi-source prescription and OTC dermatologic preparations. The company’s products include apexicon e cream, cutivate lotion, oxistat, solaraze gel, veregen, adapalene cream 0.1% (Rx), alclometasone dipropionate cream USP 0.05% (Rx), alclometasone dipropionate ointment USP 0.05% (Rx), amcinonide cream USP 0.1% (Rx), betamethasone dipropionate lotion USP 0.05% (Rx), etc. It has developed 60 FDA-approved topical therapies. The company markets its products through its brand names Fougera, PharmaDerm and Savage Laboratories. Fougera Pharmaceuticals is headquartered in Melville, New York, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.